Metraipolis › archive › dc_63d2fcfb430e

Pharmacological characterization and preclinical evaluation of 11h: a novel, brain-penetrant PDE4 inhibitor for neurological disorders — Europe PMC PMID:41585874

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41585874
DOI
10.3389/fphar.2025.1720327
License (as archived)
solo-consultazione
Archived
2026-11-06T23:19:40.632Z
SHA-256 of the archived text
a3699f4b4302930dfca9cdbb9f1a135943ebc3c59a236b81c7ddd3dbd3425027
Stable URL of this page
https://metraipolis.com/documento/dc_63d2fcfb430e

How to cite

Pharmacological characterization and preclinical evaluation of 11h: a novel, brain-penetrant PDE4 inhibitor for neurological disorders — Europe PMC PMID:41585874 — Europe PMC (en), https://europepmc.org/article/MED/41585874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_63d2fcfb430e (Metraipolis archive dc_63d2fcfb430e, sha256 a3699f4b4302930dfca9cdbb9f1a135943ebc3c59a236b81c7ddd3dbd3425027)
BibTeX
@misc{dc63d2fcfb430e,
  title = {Pharmacological characterization and preclinical evaluation of 11h: a novel, brain-penetrant PDE4 inhibitor for neurological disorders — Europe PMC PMID:41585874},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41585874},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_63d2fcfb430e; sha256 a3699f4b4302930dfca9cdbb9f1a135943ebc3c59a236b81c7ddd3dbd3425027},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41585874. Agents can read the archived copy with the MCP tool read_document.